NCT00494234 Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00494221 A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX Status COMPLETED Phase PHASE1/PHASE2
NCT00489853 Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD Status COMPLETED Phase PHASE4
NCT00489268 Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years Status COMPLETED Phase NA
NCT00486798 FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis Status TERMINATED Phase PHASE3
NCT00486265 Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) Status TERMINATED Phase PHASE1
NCT00481845 Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer Status TERMINATED Phase PHASE2
NCT00479089 Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT00477581 A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00475956 Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT00473655 Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients Status COMPLETED Phase PHASE4
NCT00473616 Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan Status TERMINATED Phase PHASE1
NCT00471367 Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 Status TERMINATED Phase PHASE1
NCT00468715 Bicalutamide in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2